696 Owsianik et al.
(film): ν = 3030, 2938, 2866, 1454, 1211, 1106, 1053,
1067, 739, 700 cm−1.1H NMR (200 MHz, CDCl3):
δ = 7.70–7.05 (m, 10H), 4.50–3.95 (m, 3H), 3.80
(dd, J = 10.8, 10.9 Hz, 1H), 3.40 (dd, J = 12.1, 12.4
Hz, 1H), 3.06 (dd, J = 11.5, 11.5 Hz, 1H), 2.82 (s,
3H), 2.78 (s, 3H), 2.05–1.85 (m, 2H), 1.82–1.45 (m,
3H), 1.43–1.05 (m, 3H), 1.04–0.65 (m, 2H) ppm. 31P
NMR (81 MHz, CDCl3): δ = 28.1 (s) ppm. 13C NMR
(50 MHz, CDCl3): δ = 138.8 (d, J = 5.0 Hz), 136.5,
128.9, 128.7, 128.3, 127.7, 127.5, 127.2 (s), 63.4 (d,
J = 9.5 Hz), 62.5 (d, J = 7.0 Hz), 46.1 (s), 45.5 (d, J =
4.5 Hz), 38.8 (d, J = 104.8 Hz), 29.0 (d, J = 8.4 Hz),
28.5 (d, J = 9.0 Hz), 26.9, 24.7 (s) ppm. MS(FAB)
415 (M-BF4). HRMS (FAB) calcd. for C23H32OPSN2
[M – BF4]+ 415.1973; found 415.1989.
X-Ray Crystallography
Crystal Data for {[1,3-bis(phenylmethyl)octa-
hydro-2-oxide-(3aR,7aR)-1H-1,3,2-benzodiazaphos-
phol-2-yl]methyl}(dimethyl)sulfonium Tetrafluorobo-
rate 4a. C23H32N2OPS·BF4, colorless, needle 0.35
× 0.15 × 0.10 mm, orthorhombic, space group
P212121, a = 8.6160 (2), b = 9.2538 (2), c = 31.9945
3
˚
˚
(8) A, V = 2550.95 (10) A , Mr = 502.36, Z = 4,
dcalcd = 1.308 g cm−3, μ = 0.24 mm−1, T = 296 (2) K,
F(000) = 1056 (see Table 3). Data collection: Kuma
KM4 CCD area-detector diffractomer with graphite
monochromatized Mo Kα radiation. Measured
reflections 45,044 (θmax 27.0°), 5376 independent
(Rint 0.029). Structure solution: direct method,
anisotropic refinement on F2 for all non-H atoms,
hydrogen atoms attached to C atoms were included
using a riding model. The structure was refined
over 3707 reflections with I >2 σ (I) (300 refined
parameters with 12.4 reflections on parameter). The
correct absolute structure was proved by the Flack
parameter [27] x = –0.10 (10). For all data, the final
wR2 was 0.144, R1 = 0.043, S = 1.12, max. ꢀρ =
{[1,3-Bis(1-methylethyl)octahydro-2-oxide-(3aR,
7aR)-1H-1,3,2-benzodiazaphosphol-2-yl]methyl}
(dimethyl)sulfonium Tetrafluoroborate 4b. Glassy
25
white solid; 90% yield; [α]D = –24 (CHCl3, 1). IR
(film): ν = 3028, 2944, 2870, 1208, 1064, 1071, 736
cm−1.1H NMR (200 MHz, CDCl3): δ = 4.10–3.65 (m,
2H), 3.65–3.40 (m, 2H), 3.18 (s br, 6H), 3.08–2.75
(m, 2H), 2.34–1.97 (m, 2H), 1.97–1.65 (m, 2H),
1.60–1.08 (m, 4H), 1.35 (d, J = 5.9 Hz, 6H), 1.25 (d,
J = 5.9 Hz, 6H) ppm. 31P NMR (81 MHz, CDCl3):
δ = 24.2 (s) ppm. 13C NMR (50 MHz, CDCl3): δ =
62.8 (d, J = 7.8 Hz), 58.9 (d, J = 6.0 Hz), 45.4 (d, J =
3.0 Hz), 43.0 (d, J = 4.0 Hz), 37.5 (d, J = 108.0 Hz),
30.6 (d, J = 7.0 Hz), 28.9 (d, J = 9.2 Hz), 24.8, 24.0,
22.6 (s), 22.0 (d, J = 4.0 Hz), 21.1, 20.9 (s), 20.5 (d,
J = 6.5 Hz) ppm. MS (FAB) 319 (M – BF4). Anal.
Calcd. for C15H32N2POSBF4 (406.27): C, 44.34; H,
7.95. Found: C, 44.28; H, 7.92.
0.32 e A−3. Data processing was carried out with
˚
the Oxford Diffraction [28, 29]; structure solution
SHELXS [30]; structure refinement SHELXL [31].
SUPPLEMENTARY MATERIAL
Full details (excluding the structure factors) for the
structure reported in this paper have been deposited
at the Cambridge Crystallographic Data Center, as
supplementary publication no. CCDC 976694 and
can be obtained free of charge on application to
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK
(e-mail: deposit@ccdc.cam.ac.uk).
{[1,3-Bis(2,2-dimethylpropyl)octahydro-2-oxide-
(3aR,7aR)-1H-1,3,2-benzodiazaphosphol-2-yl]meth-
yl}(dimethyl)sulfonium Tetrafluoroborate 4c. Glassy
yellowish solid; 95% yield; [α] = –22 (CHCl3, 1).
IR (film): ν = 3032, 2941, 2851, 1452, 1207, 1050,
1073, 732 cm−1.1H NMR (200 MHz, CDCl3): δ =
4.15–3.95 (m, 1H), 3.80–3.56 (m, 1H), 3.15 (s, 6H),
3.05–2.23 (m, 4H), 1.92–1.71 (m, 2H), 1.58–1.10
(m, 4H), 1.10–0.90 (m, 4H), 0.96 (s, 9H), 0.93 (s,
9H) ppm. 31P NMR (81 MHz, CDCl3): δ = 31.1 (s)
ppm. 13C NMR (50 MHz, CDCl3): δ = 64.6 (d, J
= 8.6 Hz), 64.0 (d, J = 11.0 Hz), 57.7 (s), 55.5 (d,
J = 28.1 Hz), 54.4 (d, J = 33.6 Hz), 38.2 (d, J = 98.5
Hz), 32.9, 31.7, 30.9, 28.6, 28.3, 27.3, 27.1, 24.3,
22.9 (s) ppm. MS(FAB) 375 (M – BF4). Anal. Calcd.
for C19H40N2POSBF4 (462.46): C, 49.34; H, 8.74.
Found: C, 49.29; H, 8.72.
REFERENCES
[1] Kukhar, V. P.; Hudson, H. R. (Eds.). Aminophospho-
nic and Aminophosphinic Acids: Chemistry and Bio-
logical Activity; Wiley: Chichester, UK, 2000.
[2] Łyz˙wa, P.; Błaszczyk, J.; Sieron´, L.; Mikołajczyk, M.
Eur J Org Chem 2013, 2106–2115.
[3] Mikołajczyk, M. J Organomet Chem 2005, 690, 2488–
2496.
[4] Midura, W. H.; Mikołajczyk, M. Tetrahedron Lett
2002, 43, 3061–3065.
[5] Midura, W. H.; Krysiak, J.; Mikołajczyk, M. Tetrahe-
dron: Asymmetry 2003, 14, 1245–1249.
[6] Krysiak, J.; Midura, W. H.; Wieczorek, W.;
Mikołajczyk, M. Tetrahedron: Asymmetry 2010, 21,
1486–1493.
[7] (a) Midura, W. H. Synlett 2006, 733–736; (b) Midura,
W. H. Tetrahedron Lett 2007, 48, 3807–3910; (c)
Cypryk, M.; Midura, W. H. Tetrahedron: Asymmetry
2010, 21, 177–186.
Heteroatom Chemistry DOI 10.1002/hc